ANVISA registration 82444370413Active

GLYCATED HEMOGLOBIN (HbA1C)

Name: GLYCATED HEMOGLOBIN (HbA1C) — ANVISA registration 82444370413
Creator: ARKRAY FACTORY INC
Keywords: GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), COLUMN UNIT 80, 82444370413, Risk Class II, ANVISA registration

ANVISA Registration Number: 82444370413Enzytec Biotecnologia Ltda.ARKRAY FACTORY INCRisk Class II

Verified

Device names

Technical name: GLYCATED HEMOGLOBIN (HbA1C)
Commercial name: COLUMN UNIT 80
Risk class: Class II

Registration details

Registration Number: 82444370413
Process Number: 25351104535202647
CNPJ: 07214566000165

Company information

Registration Holder: Enzytec Biotecnologia Ltda.
Manufacturer: ARKRAY FACTORY INC
Manufacturing Country: Japan

Dates and status

Publication Date: Jun 29, 2026
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370413 and manufactured by ARKRAY FACTORY INC. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.